N.V. Nutricia Patent applications |
Patent application number | Title | Published |
20160136210 | SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS - The invention concerns the use of prebiotics and probitics for the treatment of infections in allergic patients. | 05-19-2016 |
20160129024 | NON-DIGESTIBLE OLIGOSACCHARIDES FOR ORAL INDUCTION OF TOLERANCE AGAINST DIETARY PROTEINS - Compositions and methods for providing infant nutrition with partially hydrolysed proteins and non-digestible oligosaccharides for use in induction of oral tolerance against native dietary proteins. | 05-12-2016 |
20160128372 | MUSCLE PRESERVATION IN OVERWEIGHT OR OBESE ADULT DURING WEIGHT LOSS PROGRAM - The invention pertains to the use of a composition comprising per serving between 50-300 kcal; between 10 g and 35 g proteinaceous matter; and at least 2.5 microgram vitamin D, for the manufacture of a nutritional product for (a) the treatment or prevention of muscle mass decrease, (b) stimulation of muscle mass increase; or (d) stimulating muscle mass preservation, in obese or overweight adults of at least 40 years of age participating in a weight loss program. The inventors surprisingly found that nutritional supplementation with a low-caloric composition rich in protein, particularly whey protein and leucine, compared to an iso-caloric control supplement without protein, synergistically leads to preservation of muscle mass during a weight loss program involving a hypocaloric diet and a resistance exercise program in overweight/obese older adult. | 05-12-2016 |
20160100618 | METHOD FOR STIMULATING THE INTESTINAL FLORA - The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different | 04-14-2016 |
20160089400 | FERMENTED NUTRITIONAL COMPOSITION WITH THIOL PROTEASE INHIBITOR - The present invention relates to fermentation of milk-derived nutritional compositions to increase thiol protease inhibitor activity, and uses thereof with the products obtained. | 03-31-2016 |
20160082078 | LIQUID CONCENTRATED FORMULA - The invention pertains to a liquid complete nutritional composition suitable for feeding cachectic patients, having an energy density of at least 1.45 kcal/ml. The composition comprises a protein fraction in an amount of 7.8-12 g per 100 ml, a carbohydrate fraction, and a lipid fraction. At least 70 wt. % of the protein fraction can be obtained by demineralising milk, e.g. by ultrafiltration. The carbohydrate fraction (17-27 g per 100 ml) can comprise 0-35 wt. % of sucrose, 15-45 wt. % of other non-reducing mono-, di- and/or trisaccharides, especially trehalose, 5-50 wt. % of other mono- and disaccharides and 5-40 wt. % of tri- and higher saccharides. The product is suitably packaged in small volumes (10-150 ml). | 03-24-2016 |
20160082054 | SYNBIOTIC COMPOSITION FOR INFANTS - There is provided a preparation comprising | 03-24-2016 |
20160081963 | METABOLIC IMPRINTING EFFECTS OF SPECIFICALLY DESIGNED LIPID COMPONENT - The invention relates to the use of specifically designed lipid component with optimal fatty acid profile, an enhanced portion of the palmitic acid residues in the sn-2 position and present as lipid globules with a phospholipid coating for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life. | 03-24-2016 |
20160073669 | INTESTINAL BARRIER INTEGRITY - The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides. | 03-17-2016 |
20160058869 | PALATABLE NUTRITIONAL COMPOSITION COMPRISING A NUCLEOTIDE AND/OR A NUCLEOSIDE AND A TASTE MASKING AGENT - The present invention relates to the use of a taste masking agent selected from the group of starch; cellulose; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleoside and/or a nucleotide. It also relates to a nutritional composition comprising an unsavoury nucleoside and/or nucleotide component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell. In particular, it relates to a composition comprising said unsavoury nucleoside and/or nucleotide component, in particular comprising an uridine-containing nucleoside and/or a nucleotide in combination with an unsavoury edible oil, such as a fish oil. | 03-03-2016 |
20160058806 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH - The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides. | 03-03-2016 |
20160050960 | FERMENTED NUTRITION WITH NON-DIGESTIBLE OLIGOSACCHARIDES WITH INCREASED IRON BIOAVAILABILITY - The present invention relates to fermented nutritional compositions comprising non-digestible oligosaccharides for improving the bioavailability of iron and preventing or treating of iron deficiency, in particular for infants and young children or pregnant women. | 02-25-2016 |
20160044945 | FERMENTED NUTRITION HIGH IN LACTOSE WITH INCREASED IRON BIOAVAILABILITY - The present invention relates to fermented nutritional compositions comprising high concentration of lactosem such as 6 grams per 100 ml, and optionally non-digestible oligosaccharides, such as galactooligosaccharides or fructooligosaccharides for improving the bioavailability of iron and preventing or treating of iron deficiency (anaemia), in particular for infants and young children or pregnant women. In another aspect of the invention, the nutritional composition are used for preventing cognitive disorders and/or socio-emotional disorders in an infant and/or young child. | 02-18-2016 |
20160044933 | PROCESS AND SYSTEM FOR PREPARING DRY MILK FORMULAE - The invention relates to a process for treating animal skim milk and sweet whey and/or acid whey, comprising: (a) ultrafiltration (UF1) of a first liquid composition comprising animal skim milk with 70-90 wt % casein and 10-30 wt % whey proteins, based on total protein, over a first ultrafiltration membrane having a molecular weight cut-off of 2.5-25 kDa using a volume concentration factor of 1.5-6 to obtain a retentate (UFR1) and a permeate (UFP1); (b) ultrafiltration (UF2) of a second liquid composition comprising sweet whey and/or acid whey over a second ultrafiltration membrane having a molecular weight cut-off of 2.5-25 kDa using a volume concentration factor of 2-15 to obtain a retentate (UFR2) and a permeate (UFP2); and (c) mixing the UF retentate originating from step (a) with the UF retentate originating from step (b) to obtain a mixture of UF retentates. | 02-18-2016 |
20160044932 | PROCESS AND SYSTEM FOR PREPARING DRY MILK FORMULAE - A process and system is disclosed for obtaining a dry milk formula, comprising (a-i) ultrafiltration of an animal skim milk composition comprising 70-90 wt % casein and 10-30 wt % whey proteins, based on total protein, and (a-ii) ultrafiltration of an animal whey composition comprising 0-25 wt % casein and 75-100 wt % whey proteins, based on total protein; or (a-iii) ultrafiltration of a mixture of the compositions of (a-i) and (a-ii), (b) removing polyvalent ions from the UF permeate originating from step (a-i) and/or (a-ii) or (a-iii) to obtain at least one softened UF permeate; (c) combining the at least one softened UF permeate with a UF retentate to obtain a combined product; and (d) drying the combined product to obtain a dry milk formula. | 02-18-2016 |
20160001941 | LOW PROFILE SCOOP - A low profile scoop for dosing of powdered infant formula has a handle portion and a bowl with an open mouth and a closed underside. The bowl has a width that is relatively smaller than both its length and its depth, allowing it to be placed on its side in areas of relatively low head space. The scoop may be used in package for powdered infant nutrition including a tub defining a product containing space and a lid having limited head space. | 01-07-2016 |
20150368033 | A CAPSULE FOR BEVERAGE DISPENSING APPARATUS - A capsule ( | 12-24-2015 |
20150366919 | SYNBIOTICS COMBINATION FOR BRAIN IMPROVEMENT - The invention relates to nutritional compositions with | 12-24-2015 |
20150352178 | LOW PROTEIN INFANT FORMULA WITH INCREASED ESSENTIAL AMINO ACIDS - The present invention concerns an improved balance of the essential branched chain amino acids leucine, isoleucine and valine in infant formula. | 12-10-2015 |
20150351437 | METHOD FOR THE PREPARATION OF A LIQUID ENTERAL NUTRITIONAL COMPOSITION COMPRISING MICELLAR CASEIN - The invention relates to a method for preparing a shelf-stable liquid enteral composition for providing nutrition, either as a supplement, or as a complete nutrition, comprising a high amount of micellar casein, comprising dissolving a dry blend of micellar casein and digestible carbohydrate. | 12-10-2015 |
20150335602 | IMPROVEMENT OF COGNITIVE FUNCTION IN PRETERM INFANTS THAT ARE SMALL FOR GESTATIONAL AGE - The present invention relates to the use of nutritional compositions enriched in glutamine to improve structural and functional brain development in preterm infants that born small for gestational age. | 11-26-2015 |
20150335053 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 11-26-2015 |
20150306117 | INFANT NUTRITION FOR IMPROVING FATTY ACID COMPOSITION OF BRAIN MEMBRANES - The present invention relates to infant nutrition, in particular to infant nutrition comprising special lipid globules for improvement of the fatty acid composition in brain membranes. | 10-29-2015 |
20150305387 | NUTRITIONAL COMPOSITION WITH NON DIGESTIBLE OLIGOSACCHARIDES - The present invention relates to the use of non digestible oligosaccharides above a certain threshold for improving health of the small intestine, in particular in infants and small children, by increasing the luminal fluid volume and reducing the protease activity or density. | 10-29-2015 |
20150305383 | PRETERM MILK FORMULA - The present invention relates to a protein fortifier for use in varying the amount of protein in preterm infant nutrition, thereby adapting the formula or human milk to the nutritional needs of very low birth weight infants and extremely low birth weight infants. | 10-29-2015 |
20150297622 | PRODUCT AND METHOD FOR SUPPORTING URIDINE HOMEOSTASIS - This invention pertains to the use of an uridine source, preferably uridine monophosphate, for increasing, controlling and/or maintaining fasting plasma uridine concentrations in a range of 4 to 8 μM in a subject in need thereof, comprising administering to said subject a composition comprising 300-900 mg of said uridine source daily for a period of at least 4 weeks. In particular, the use of an uridine source is intended forelderly and/or subjects suffering from neurological disorders such as Alzheimer's Disease and dementia syndromes. | 10-22-2015 |
20150272191 | FORMULAS COMPRISING OPTIMISED AMINO ACID PROFILES - The present invention relates to infant formulas and follow-on formulas containing optimised amino acid profiles. The formulas may contain intact proteins, hydrolysed proteins, protein fractions, free amino acids and/or a combination thereof selected based on their ability to provide the formula with an optimised amino acid profile. The present invention also relates to the administration of these formulas to infants in order to achieve balanced growth and/or development, and may also assist in preventing or reducing the risk of obesity later in life. | 10-01-2015 |
20150265540 | INFANT NUTRITION WITH LIPID GLOBULES TO INCREASE ENERGY EXPENDITURE AND METABOLIC FLEXIBILITY LATER IN LIFE - The present invention relates to nutrition for infants and young children with particular lipid globules, resulting in programming the metabolism to an increased energy expenditure and improved mitochondrial functioning later in life when exposed to a high fat, high energy diet. | 09-24-2015 |
20150250851 | PEA-BASED PROTEIN MIXTURE AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING - This invention relates to a pea-based protein mixture and use thereof in a liquid nutritional composition, in particular suitable for tube feeding, and further relates to said liquid nutritional composition for providing long-term complete enteral nutrition to patients in need thereof. More specifically, the pea-based protein mixture and the liquid nutritional composition comprising said pea-based protein mixture comprises more than 25 weight % and up to 80 weight % of vegetable protein comprising a source of intact pea protein and a source of intact soy protein. The invention relates further to a method for long-term enteral nutrition of patients in need thereof comprising administering an effective amount of said liquid nutritional composition comprising said pea-based protein mixture, in particular comprising a defined amount of intact pea protein and a second vegetable intact protein, other than pea protein. | 09-10-2015 |
20150250807 | USE OF NON-DIGESTIBLE SACCHARIDES FOR GIVING AN INFANT THE BEST START AFTER BIRTH - A food or supplement for pregnant women comprising water soluble, non-digestible saccharides is described. The composition is used to improve the flora and/or immune system of the pregnant women, to improve the immune system of the infant and to improve the intestinal flora of the infant after birth. | 09-10-2015 |
20150246090 | NON-DIGESTIBLE OLIGOSACCHARIDES FOR ORAL INDUCTION OF TOLERANCE AGAINST DIETARY PROTEINS - Compositions and methods for providing infant nutrition with partially hydrolysed proteins and non-digestible oligosaccharides for use in induction of oral tolerance against native dietary proteins. | 09-03-2015 |
20150190464 | METHOD FOR PRODUCING A PROTEIN COMPRISING COMPOSITION WITH REDUCED DIGESTIVE COAGULATION - The present invention relates to a process of producing a composition comprising at least two different proteins, of which at least one is a coagulating protein and at least one is an anti-coagulating protein, comprising the steps of: a) heat-sterilising a first liquid component comprising said coagulating protein, b) heat-sterilising a second liquid component comprising said anti-coagulating protein, and c) mixing said first component with said second component to obtain a mixture thereof. The obtained mixture is useful as a food constituent having reduced coagulation in the upper gastro-intestinal tract, more in particular in the stomach. | 07-09-2015 |
20150174192 | PEA PROTEIN PEPTIDES WITH ANTI HELICOBACTER PYLORI ACTIVITY - The invention relates to a composition comprising pea protein hydrolysate for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular | 06-25-2015 |
20150173561 | SYSTEM FOR THE PREPARATION OF BEVERAGES | 06-25-2015 |
20150173405 | METABOLIC IMPRINTING EFFECTS OF NUTRITION WITH LARGE LIPID GLOBULES COMPRISING MILK FAT AND VEGETABLE FAT - The invention relates to the use of specifically designed lipid component with a mixture of milk fat and vegetable fat and present as lipid globules with a large size, for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life. | 06-25-2015 |
20150157534 | FLEXIBLE CONTAINER WITH OUTLET - A container for a liquid nutritional product includes a thermoformed polymeric container body having a base and an upstanding sidewall defining a product space, the upstanding sidewall terminating at a peripheral flange. A cover is permanently sealed to the peripheral flange and an outlet is provided on an outlet region of the container body. The outlet defines a flow channel for the liquid nutritional product to leave the product space and, in a storage condition, the flow channel is directed at least partially downwards in a direction away from the cover and towards the base. For administration, the outlet region is deformable to an administration position where the flow channel is directed sideways in a direction parallel to the base. | 06-11-2015 |
20150132365 | FERMENTED INFANT FORMULA WITH NON DIGESTIBLE OLIGOSACCHARIDES - The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation. | 05-14-2015 |
20150125569 | PRETERM FORMULA - The present invention relates to a method and a composition for feeding low birthweight infants (LBW infants), very low birthweight infants (VLBW infants), extremely low birthweight infants (ELBW infants) and preterm infants for improving oral tolerance. | 05-07-2015 |
20150118350 | INFANT FORMULAE AND THEIR PREPARATIONS - The invention pertains to an infant formula powder composition comprising micronized lactose or lactose microcrystals (i) smaller than 30 micrometer, and/or (ii) of which at least 80% has a size less than 20 micrometer, and/or (iii) at least 80% has a size less than 10 micrometer, and/or (iv) having a median particle size D50 below 10 micrometer. The invention also pertains to the use of micronized lactose or lactose microcrystals for improving flow of an infant formula powder composition. | 04-30-2015 |
20150093490 | PROCESS FOR THE HUMANIZATION OF ANIMAL SKIM MILK AND PRODUCTS OBTAINED THEREBY - The invention relates to a process for the treatment of animal skim milk and for the production of an infant formula base product from animal skim milk, which process is highly efficient and cost effective, as only membrane filtration techniques, such as microfiltration and ultrafiltration, are required. By carefully controlling the process parameters, a product is obtained in which most of the major components are within the desired range for an infant formula base product. The invention also relates to products obtainable by the process according to the invention. | 04-02-2015 |
20150080334 | MATERNAL SUPPLEMENT TO ENHANCE IMMUNE SYSTEM OF AN INFANT - There is provided compositions and methods for enhancing an immune system and/or preventing an immune system related disorder in a mammalian subject, the composition comprising a non-digestible oligosaccharide which is to be administered to a female who is breast-feeding the mammalian subject. | 03-19-2015 |
20150044138 | METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY - The invention relates to a composition comprising: (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, for use in preserving or improving functional synaptic connectivity and/or preserving brain network organization in a subject in need thereof. | 02-12-2015 |
20150038453 | PREPARATION FOR USE OF ASPARTATE AND VITAMIN B12 OR BIOTIN FOR REGULATING KETONE BODIES - It has been found that high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, especially in relative absence of glutamate equivalents, improve the metabolism of ketobodies and/or lactate in a mammal's body, especially in diseased or traumatic conditions. As a result, levels of ketobodies and lactate can be decreased and unphysicologically high acidity normalised. Thus, it is an object of the invention to provide an enteral nutritional or a pharmaceutical composition for the treatment and/or prevention of disturbed ketone and lactate metabolism, i.e. elevated concentrations of ketone bodies, lactate and/or other organic acids and/or insufficient pH homeostasis, especially elevated concentrations of ketone bodies and/or lactate, in a mammal's blood, wherein the composition comprises high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, preferably in relative absence of glutamate equivalents. | 02-05-2015 |
20150037309 | PREPARATION FOR IMPROVING THE ACTION OF RECEPTORS - The present invention relates to the use of
| 02-05-2015 |
20150024082 | GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS - The present invention relates to the use of nutritional compositions enriched in glutamineto improve structural brain development in preterm and/or low birth weight infants. | 01-22-2015 |
20140377405 | EARLY STIMULATION OF TASTE AND/OR FLAVOUR ACCEPTANCE - The invention relates to a kit of parts comprising 2 to 100 containers each containing an infant formula, wherein each infant formula is in a form suitable for administration to an infant and/or toddler or in a form suitable for administration to an infant and/or toddler after admixing with an aqueous liquid, wherein the kit of part comprises at least two different infant formulas which differ from each other in taste and/or flavour by having a different protein fraction or by being a fermented infant formula, wherein each of the different protein fractions is selected from the group consisting of intact milk proteins including cow milk proteins, intact plant proteins including soy protein, hydrolysed proteins, free amino acids, or mixtures of two or more thereof. | 12-25-2014 |
20140364361 | HIGH PROTEIN LIQUID ENTERAL NUTRITIONAL COMPOSITION - The present invention relates in general to a shelf-stable liquid enteral composition for providing nutrition, either as a supplement, or as a complete nutrition, with a high protein content of a non-hydrolysed globular protein, in particular a whey protein. | 12-11-2014 |
20140357571 | GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS - The present invention relates to the use of nutritional compositions enriched in glutamine to improve structural and functional brain development in preterm and/or low birth weight infants. | 12-04-2014 |
20140335221 | TEMPORALLY MEAL MENU FOR INFANTS - The invention concerns a kit of parts and a method for providing nutrition which provides within a time period of 5 to 10 days a nutritional composition comprising 0.35 to 6 mg iron per 100 g, a nutritional composition comprising 1 to 10 g fibre per 100 g and a nutritional composition comprising 10 to 5000 mg long chain poly unsaturated fatty acids per 100 g to an infant. | 11-13-2014 |
20140335129 | NON-DIGESTIBLE OLIGOSACCHARIDES FOR ORAL INDUCTION OF TOLERANCE AGAINST DIETARY PROTEINS - Compositions and methods for providing infant nutrition with partially hydrolysed proteins and non-digestible oligosaccharides for use in induction of oral tolerance against native dietary proteins. | 11-13-2014 |
20140335073 | NUTRITION FOR PREVENTION OF INFECTIONS - A nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by | 11-13-2014 |
20140328979 | UNIT DOSE PACKAGE FOR NUTRITIONAL PRODUCT - A unit dose package of a liquid nutritional product comprises a form-stable, cup shaped container with a capacity of less than 70 ml having a rim, a frustoconical sidewall and a base. A quantity of the nutritional product is enclosed within the container and a foil closure is sealed to the rim. The container is formed of a laminate comprising a barrier layer of highly 5 orientable EVOH having an ethylene content of less than 31 mol %, preferably around 27 mol %, and an oxygen transmission of less than 0.0068 ml/ml/year, between an inner carrier layer and an outer carrier layer. The package is especially adapted for long term storage of oxygen sensitive products. | 11-06-2014 |
20140308391 | COMPOSITION WITH SYNBIOTICS - Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed. | 10-16-2014 |
20140303067 | TREATMENT OF EOSINOPHILIC ESOPHAGITIS - The present invention provides a method for the treatment of eosinophilicesophagitis comprising administering non-digestible oligosaccharides. | 10-09-2014 |
20140296179 | NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES - The present invention provides a method and composition for the treatment and/or prevention of infection, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and immunoglobulin from the milk or colostrum of hyperimmunized cows. | 10-02-2014 |
20140296162 | Whey Protein Composition with a Reduced Astringency - The invention relates to a sterilized liquid or semi-solid acid enteral composition comprising per 100 ml 9 to 20 g of non-hydrolysed globular proteins, fat and at least 100 mg of divalent metal cations and having a pH ranging between 3 and 5. The invention further relates to a method for preparing a composition according to the invention, comprising a step wherein at least the non-hydrolysed globular proteins are subjected to a direct steam injection (DSI) at specific holding values, such as a holding temperature of 100 to 140° C. during a holding time of about 0.5 to 10 seconds, followed by a homogenization step and a sterilization step The composition according to the invention has a reduced astringency and can be used for medical purposes, such as for stimulating muscle protein synthesis in a mammal, in particular for treating sarcopenia, and for specific groups of people, such as elderly and sportsman. | 10-02-2014 |
20140274938 | IMPROVING RECOGNITION - The invention relates to a composition for use in the treatment or prevention of recognition dysfunction, and/or for improving recognition, in a (prodromal) Alzheimer's patient, in particular in a drug-naive (prodromal) Alzheimer's patient, more particularly in a subject with a mini-mental state examination of 20-30. | 09-18-2014 |
20140248391 | USE OF INFANT FORMULA WITH LARGE LIPID GLOBULES - The invention relates to infant nutrition comprising large lipid globules. This infant nutrition has programming effects on the body and results in a reduced level of total blood cholesterol later in life when consuming a Western style diet. Thereby the risk on western life style diseases as atherosclerosis and other vascular diseases later in life can be reduced. | 09-04-2014 |
20140234475 | SENSORIC IMPRINTING - The invention concerns a method for exposing an infant to multiple different tastes of food products and stimulating the consumption of e.g. vegetables and fruit later in life. | 08-21-2014 |
20140220174 | PROCESS FOR PRODUCING SLOWLY DIGESTIBLE STARCH - A sterilized food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 μm, at least 90 wt. % of the starch particles having a particle diameter of less than 50 μm; and (c) a non-digestible starch content of less than 50 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesity, insulin resistance, or for postprandial glucose response. | 08-07-2014 |
20140212540 | COMPOSITION WITH FAT GRADIENT - The present invention concerns infant formula having a fat gradient which can be established by a sufficient amount of fat droplets with a diameter of 5-25 μm based on total weight of fat. | 07-31-2014 |
20140200195 | METHOD FOR REDUCING THE OCCURRENCE ON INFECTION IN YOUNG CHILDREN - The invention pertains to the use of a composition in reducing the number of infections episodes and the occurrence of infections in young children, said composition comprising: (a) long chain polyunsaturated fatty acids, wherein the amount of arachidonic acid is less than 0.06 gram per 100 gram fatty acid; and comprising, per 100 g fatty acids: (i) 0.3-0.6 gram docosahexaenoic acid; (ii) 0.2-0.4 gram eicosapentaenoic acid; and (b) between 1.5 and 2.5 gram indigestible oligosaccharides per 100 kcal, comprising: (i) 1.4-2 gram short-chain galactooligosaccharides; and (ii) 0.1-0.5 gram long-chain fructopolysaccharides. | 07-17-2014 |
20140199431 | LIQUID TRANSITION NUTRITION FOR INFANTS - Liquid composition suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid foods with a viscosity 20-150 mPas, containing a digestible carbohydrate fraction and an indigestible carbohydrate fraction with at least 50 wt. % soluble indigestible oligosaccharide with a degree of polymerisation (DP) between 2 and 100. | 07-17-2014 |
20140187513 | METHOD OF IMPROVING SKILLS WITH A COMPOSITION COMPRISING NON-DIGESTIBLE SACCHARIDE - The present invention concerns a therapy aimed at language and/or social skills in infants through administration of components stimulating the development of a healthy intestinal flora. | 07-03-2014 |
20140187480 | METABOLIC IMPRINTING EFFECTS OF SPECIFICALLY DESIGNED LIPID COMPONENT - The invention relates to the use of specifically designed lipid component with optimal fatty acid profile, an enhanced portion of the palmitic acid residues in the sn-2 position and present as lipid globules with a phospholipid coating for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life. | 07-03-2014 |
20140170260 | METABOLIC IMPRINTING EFFECTS OF SPECIFICALLY DESIGNED LIPID COMPONENT - The invention relates to the use of specifically designed lipid component with optimal fatty acid profile, an enhanced portion of the palmitic acid residues in the sn-2 position and present as lipid globules with a certain size for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life. | 06-19-2014 |
20140162973 | PALATABLE NUTRITIONAL COMPOSITION COMPRISING A NUCLEOTIDE AND/OR A NUCLEOSIDE AND A TASTE MASKING AGENT - The present invention relates to the use of a taste masking agent selected from the group of starch; cellulose; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleoside and/or a nucleotide. It also relates to a nutritional composition comprising an unsavoury nucleoside and/or nucleotide component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell. In particular, it relates to a composition comprising said unsavoury nucleoside and/or nucleotide component, in particular comprising an uridine-containing nucleoside and/or a nucleotide in combination with an unsavoury edible oil, such as a fish oil. | 06-12-2014 |
20140135257 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION - The invention relates to the use of one or more nucleotides for improving the heat stability of an aqueous micellar casein composition comprising 6 to 20 g per 100 ml of micellar casein, and having a pH of about 6 to 8. The invention also relates to heat-treated liquid nutritional compositions comprising 6 to 20 g, preferably 9-20 g, of protein per 100 ml of the composition and having a pH of about 6 to 8, in which all or a major part of said protein comprises micellar casein, further comprising one or more nucleotides. | 05-15-2014 |
20140106025 | INFANT NUTRITION WITH HYDROLYSED PROTEINS - The invention concerns a method to treat and/or prevent childhood obesity comprising administering a nutritional composition containing fat, digestible carbohydrates and protein, wherein the protein comprises at least 25 wt. % peptides with a chain length of 2 to 30 amino acids based on dry weight of protein. | 04-17-2014 |
20140105865 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 04-17-2014 |
20140100189 | CARBOHYDRATES MIXTURE - A carbohydrate mixture for dietetic foods and pharmaceuticals is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed. Carbohydrate component A may comprise at least one monosaccharide or of at least one oligosaccharide (disaccharide to hexasaccharide) or a mixture of two or more of these saccharides. Carbohydrate component B may comprise a polysaccharide (from heptasaccharide onwards) or a mixture of two or more polysaccharides. Carbohydrate component A=5 to 95 wt-% and carbohydrate component B=5 to 95 wt-% of the sum of the carbohydrate components A+B (=100 wt-%), and at least 80 wt-% of the carbohydrates/saccharides of both carbohydrate components have a prebiotic effect. The carbohydrate mixtures have not only a nutritive effect but they also stimulate health-promoting microorganisms present in the natural flora of the large intestine. | 04-10-2014 |
20140099416 | DEVICE AND A METHOD FOR PREPARING A READY TO USE LIQUID PRODUCT - A device for preparing a ready-to-use liquid product from a semi-finished product where the semi-finished product is arranged in a first container, the device having an injector for supplying an amount of liquid into the first container for providing the ready-to-use liquid product, and the injector configured to evacuate the ready-to-use liquid product from the first container into a second container. | 04-10-2014 |
20140099344 | PROCESS FOR DISPERSING AMINO ACIDS - A coated proteinaceous material can be produced by contacting the proteinaceous material with de-oiled phospholipids or mixtures thereof containing less than 20% triglycerides. The coating has between 0.1 and 1.5% by weight of the total proteinaceous material, of de-oiled lecithin. The proteinaceous material is hydrophobic, especially amino acids having a hydrophobicity of higher than 1.0 kJ/mol. In particular, the amino acids are leucine, isoleucine, valine, phenylalanine, tryptophan and/or methionine. The coated amino acids can be incorporated into food products and medicaments. | 04-10-2014 |
20140066397 | METHOD FOR TREATING NEUROTRAUMA - The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight % of □-linolenic acid (ALA), calculated on the weight of all fatty acids; iii) choline, or salts or esters thereof; for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal cord injury. | 03-06-2014 |
20140024580 | HIGH ENERGY LIQUID ENTERAL NUTRITIONAL COMPOSITION - High energy and high protein liquid nutrition enteral compositions are provided that contain micellar casein and caseinate, an optionally a small amount of whey. | 01-23-2014 |
20140023772 | PROCESS FOR THE PRODUCTION OF A POWDERED COMPOSITION, THE POWDERED COMPOSITION OBTAINED THEREBY AND USES THEREOF - The present invention relates to a process for the production of a powdered composition from a liquid composition comprising fat, protein or both, to the powdered composition obtained thereby and products containing said powdered composition. | 01-23-2014 |
20140017368 | SOLID MILKS AND METHOD FOR PRODUCING SOLID MILKS - The invention relates to a method for producing solid milks and to the products obtained with the aid of this method. The method comprises a compression step, then a moistening step, then a drying step. The compression step is carried out with a compaction ratio comprised between 50% and 80%. In the moistening step, water is sprayed on the outside surface of the said compressed and solid milk unit with an amount comprised between 0. mg and 8 mg per cm | 01-16-2014 |
20140017367 | METHOD FOR PRODUCING SOLID MILKS - The present invention relates to a method for producing solid milks and to the products obtained with the aid of this method. The method for producing solid milks according to the invention comprises the following steps:—compressing milk powder at a compression speed between 110 and 200 mm/s to obtain a solid unit,—moistening the solid unit by spraying an amount of water between 0.1 and 8 mg/cm | 01-16-2014 |
20130331352 | Combination of Components for the Prevention and Treatment of Frailty - Composition comprising at least two components, more preferably at least three components, more preferably at least four components, selected from the group of (i) a nucleoside equivalent, (ii) an ω-3 polyunsaturated fatty acid selected from the group of DHA, DPA and EPA, (iii) a vitamin B, (iv) a phospholipid, (v) an antioxidant and (vi) a choline, with the proviso that at least component (i) or (iii) is present, for use in the prevention or treatment of frailty in a mammal, wherein frailty is determined by compliance with at least 2 criterions, preferably 3 criterions, selected from the group of muscle weakness, excessive feelings of exhaustion or fatigue, abnormally low physical activity, slow or unsteady gait, weight loss, and neurological dysfunction. | 12-12-2013 |
20130330424 | Non-Medical Increase or Maintenance of Body Weight of a Mammal - Non-medical use of at least two components selected from the group of: (i) nucleoside equivalents, (ii) n-3 polyunsaturated fatty acids selected from the group of DHA, DPA and EPA, (iii) vitamins B, (iv) phospholipids, (v) antioxidants and (vi) cholines—with the proviso that at least one (i) nucleoside or at least one (iii) vitamin B is present—for increasing or maintaining the body weight, for improving the ability to perform an activity of daily living of a mammal, for maintaining the ability to perform an activity of daily living of a mammal, or for reducing a deterioration in the ability to perform an activity of daily living of a mammal. | 12-12-2013 |
20130295146 | Composition for Improving Membrane Composition and Functioning of Cells - It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises:
| 11-07-2013 |
20130230503 | METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS - The present invention relates to the use of a preparation, especially a nutritional preparation, for the prevention or treatment of anxiety in a subject, especially in a depressed subject, and depression. More specifically, the present invention relates to the use of a preparation, especially a nutritional preparation, for the prevention or treatment of anxiety or depression in a subject that is non-responsive to SSRI medication. Furthermore, the invention relates to the use of a preparation, especially anutritional preparation, for regulating neurogenesis. The preparation comprises the following components: a) at least one ω-3 polyunsaturated fatty acid (PUFA); b) at least two phospholipids, selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine or any mixture thereof; and c) one or more compounds which are a factor in the serotonin metabolism, selected from the group of B vitamins and tryptophan. | 09-05-2013 |
20130219987 | Novel Glucose Tolerance Test and Composition for Use - The present invention relates to a liquid nutritional composition, to a liquid nutritional composition for use in a diagnostic method for screening of a glucose-intolerant condition, to a kit for screening of a glucose-intolerant condition, and to a diagnostic method for screening a mammal for a glucose-intolerant condition. Furthermore, it refers to a liquid nutritional composition for use as a standard reference nutrition, such as for classification of postprandial glucose responses of different nutritional compositions. The liquid nutritional composition comprises protein, fat, digestible carbohydrate and dietary fibre, wherein the digestible carbohydrate comprises at least 90 weight % of glucose units, based on total digestible carbohydrate mass and preferably is substantially free of fructose. | 08-29-2013 |
20130210763 | SYNERGISM OF GOS AND POLYFRUCTOSE - The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS). | 08-15-2013 |
20130203646 | SUPPORTING ACTIVITIES OF DAILY LIVING - The invention provides a method for supporting operational activities in daily living by providing a combination of (a) long-chain polyunsaturated fatty acids, particularly DHA and/or EPA, and (b) nucleosides or nucleotides, particularly uridine or its equivalent. The operational activities comprise eating; walking; toileting; bathing; grooming; dressing; use of communication equipment; making conversations; keeping appointments; use of household appliances; cleaning dishes; preparation of meal or drink; writing; reading; independent housekeeping; transportation and shopping. | 08-08-2013 |
20130157978 | PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS - The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
| 06-20-2013 |
20130157937 | STABLE HIGH LIPID LIQUID FORMULA - The present invention provides a ketogenic diet in the form of a sterile shelf stable ready to use formula, in particular a tube feed, comprising casein and dietary fibre. | 06-20-2013 |
20130109650 | COMPOSITION CONTAINING OLIGOSACCHARIDES FOR THE TREATMENT/PREVENTION OF INFECTIONS | 05-02-2013 |
20130102560 | NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES - The present invention provides a method and composition for the treatment and/or prevention of infection, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and immunoglobulin from the milk or colostrum of hyperimmunized cows. | 04-25-2013 |
20130096087 | INFANT NUTRITION FOR IMPROVING FATTY ACID COMPOSITION OF BRAIN MEMBRANES - The present invention relates to infant nutrition, in particular to infant nutrition comprising special lipid globules for improvement of the fatty acid composition in brain membranes. | 04-18-2013 |
20130065824 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN - Medical dairy products are highly concentrated in proteins and minerals. Formulation of such products is challenging, since viscosities can easily increase during processing and storage. It was found that using one or more chelating agents selected from the group consisting of a phosphoric acid, citric acid, a soluble phosphate salt, a soluble citrate salt, or a mixture thereof, the viscosity and the transparency of an aqueous micellar casein composition, comprising 6 to 20 g/100 ml of micellar casein and having a pH of about 6 to 8 could be controlled independently of each other. It was found that products become more viscous after addition of phytate, citrate, or orthophosphate, and that the viscosity depends on concentration and type of phosphate. Addition of hexametaphosphate leads to gel formation. In contrast, high concentrations of uridine monophosphate can be added without significantly affecting the viscosity. | 03-14-2013 |
20130053340 | INTESTINAL BARRIER INTEGRITY - The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides. | 02-28-2013 |
20130023468 | LIQUID ENTERAL NUTRITIONAL COMPOSITION SUITABLE FOR TUBE FEEDING, MINIMIZING LOWER AND UPPER TRACT DIGESTIVE CONDITIONS - The invention is directed to liquid enteral nutritional compositions comprising a protein fraction comprising more than 25 weight % and up to 80 weight % of a vegetable protein comprising at least a source of pea protein, and a fat fraction comprising (a) 8 to 15 weight % of linoleic acid; (b) 3.0 to 6.0 weight % of a combination of alpha-linolenic acid, docosahexaenoic acid and eicosapentaenoic acid, wherein the amount of ALA is >2.5 weight % and the combined amount of DHA and EPA is ≦2.5 weight %; (c) 10 to 20 weight % of at least one medium-chain fatty acid; and (d) 35 to 79 weight % of at least one mono-unsaturated fatty acid. The compositions provide for a healthy and balanced diet, which is well-tolerated and minimises clinical complications that are frequently associated with the administration of enteral nutrition in patients using tube feeding, especially with respect to a reduced gastric emptying. | 01-24-2013 |
20130018012 | LIPID COMPOSITION FOR IMPROVING BRAIN FUNCTION - The invention pertains to the use of a lipid fraction for the support of brain function. The lipid fraction comprises the medium-chain fatty acids at least 4 g hexanoic acid and/or at least 5 g octanoic acid, at least 1 g eicosapentaenoic acid, and in addition more than 0.4 g α-linolenic acid per 100 g fatty acids of the lipid fraction. | 01-17-2013 |
20130012469 | LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT - The invention pertains to a liquid composition for preventing and/or treating memory decline and/or cognitive dysfunction, Alzheimer's, Parkinson's and/or dementia, said composition comprising: (i) at least 50 mg nucleoside and/or nucleotide per 100 ml; (ii) between 0.2 and 10 grams protein per 100 ml; (iii) between 0.05 and 3 wt. % of thickener, based on total weight of the composition. The thickener is preferably selected from the group consisting of cellulose, xanthan gum, gellan gum, alginate, guar gum, locust bean gum, gum karaya, gum tragacanth, carrageenan, and mixtures thereof. The composition preferably has a loss factor tan δ between 0.1 and 100, as measured at any strain in the range of 1-100% at 0.1 Hz and 20° C. It is particularly found that a thickener selected from the group consisting of gellan gum, xanthan gum and cellulose greatly reduces sedimentation. | 01-10-2013 |
20120322756 | METABOLIC IMPRINTING EFFECTS OF STRUCTURED LIPIDS - The invention relates to the use of triglycerides which an enhanced portion of the palmitic acid residues in the sn-2 position for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life. | 12-20-2012 |
20120309831 | BALANCED FAT COMPOSITION AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING - This invention relates to a balanced fat composition and use thereof in a liquid nutritional composition, in particular suitable for tube feeding. This invention further relates to said liquid nutritional composition for providing enteral nutrition to patients in need thereof, in particular for providing a complete enteral nutrition, in particular for providing a long-term enteral nutrition. More specifically, the balanced fat composition and the liquid nutritional composition comprising said balanced fat composition comprises specific amounts of linoleic acid (LA), alpha-linolenic acid (ALA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), at least one medium chain fatty acid (MCFA), and at least one mono-unsaturated fatty acid (MUFA). The invention relates further to a method for providing enteral nutrition to patients in need thereof comprising administering an effective amount of said liquid nutritional composition comprising the balanced fat composition according to the invention. | 12-06-2012 |
20120301599 | IMPROVED NUTRITIONAL TABLET - To improve the solubility and the speed of dissolution of nutritional tablets comprising protein, fat and carbohydrates, dietary fibers are included in the nutritional tablets. | 11-29-2012 |
20120283180 | PEA-BASED PROTEIN MIXTURE AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING - This invention relates to a pea-based protein mixture and use thereof in a liquid nutritional composition, in particular suitable for tube feeding, and further relates to said liquid nutritional composition for providing long-term complete enteral nutrition to patients in need thereof. More specifically, the pea-based protein mixture and the liquid nutritional composition comprising said pea-based protein mixture comprises more than 25 weight % and up to 80 weight % of vegetable protein comprising a source of intact pea protein and a source of intact soy protein. The invention relates further to a method for long-term enteral nutrition of patients in need thereof comprising administering an effective amount of said liquid nutritional composition comprising said pea-based protein mixture, in particular comprising a defined amount of intact pea protein and a second vegetable intact protein, other than pea protein. | 11-08-2012 |
20120252723 | Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis - The present invention is directed at a combination of (i) serine, (ii) cysteine, (iii) arginine and (iv) at least one branched amino acid, for use in the therapeutic or prophylactic treatment of inflammation or infection, wherein the combination is to be administered enterally and at a combination of (i) serine, (ii) cysteine, (iii) arginine and (iv) at least one branched amino acid, for use in the therapeutic or prophylactic treatment of an imbalance in the metabolic use of amino acid resources from the body or from nutrition in a subject having an inflammation or an infection, wherein the combination is to be administered enterally. | 10-04-2012 |
20120251633 | Amino Acid Composition With Improved Dispersibility - The invention relates to agglomerated amino acid particles comprising between 1 and 95 wt % of at least one component selected from the group of amino acids and peptides, including esters thereof and salts thereof, having a solubility in water at 20 degrees Celsius of less than 5 g/100 ml, wherein said at least one component is agglomerated with at least one water soluble amino acid, which may be a free amino acid, an ester thereof or a salt thereof, having a solubility in water at 20 degrees Celsius of at least 5 g/100 ml. | 10-04-2012 |
20120165412 | Use of Resveratrol or Another Hydroxylated Stilbene For Preserving Cognitive Functioning - The present invention relates to the use of an hydroxylated stilbene, in particular resveratrol, in the manufacture of a neutraceutical composition for increasing the microvascular plasticity and/or microvessel density, and/or decreasing the microvessel abnormalities in the brain, in particular in the hippocampus of a mammal, in particular for the treatment of age- and condition-related decline in brain neuronal function and/or cognitive functioning in a mammal. In particular, the condition is selected from the group of Alzheimer's Disease, dementia, depression, sleep disorders, impaired memory function, psychoses, Parkinson's disease, Huntington's chorea, epilepsy, schizophrenia, paranoia, ADHD and anxiety. | 06-28-2012 |
20120122813 | COMPOSITION CONTAINING OLIGOSACCHARIDES FOR THE TREATMENT/PREVENTION OF INFECTIONS - The present invention relates to oligosaccharide mixtures and their use in the treatment and/or prevention of infections, and in particular, for reducing the severity of childhood infection or in the treatment and/or prevention of childhood infection. | 05-17-2012 |
20120122785 | COMBINATION OF A LEUCINE SOURCE AND AN OMEGA- 3 UNSATURATED FATTY ACID SOURCE FOR USE IN THE TREATMENT OF HYPERCALCAEMIA - The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis. | 05-17-2012 |
20120061413 | CONTAINER ASSEMBLY HAVING STACKING PROVISIONS - The invention relates to a container assembly comprising a container part with a circumferential wall and a bottom wall, and a lid part comprising a connection portion for connection to a rim of said circumferential wall and a lid which is pivotably connected to said connection portion, said connection portion comprising an upper wall provided with an access opening which can be sealed with said lid, and said connection portion is provided with stacking provisions which enclose said access opening and which are complementary with stacking provisions at the bottom of said container part. | 03-15-2012 |
20120060968 | POWDER PACKAGING - A powder packaging includes space for containing powder, an outlet opening for the powder, and a dosing device positioned on the outlet opening, the powder dosing device including a dosing body having a first closing part, a second closing part and a dosing chamber between the closing parts. The dosing body is movable between a filling position in which the dosing chamber is accessible for powder in the powder containing space and the second closing part closes off the outlet opening, and a dosing position in which the first closing part closes off the outlet opening and the dosing chamber allows powder to leave the dosing chamber and thus to exit the powder containing space. | 03-15-2012 |
20120058938 | NUTRITIONAL COMPOSITION INDUCING A POSTPRANDIAL ENDOCRINE RESPONSE - The invention concerns the use of a nutritional composition for the treatment of disorders which are associated with malfunctioning in the uptake and use of food-derived energy in the human body. In particular, the invention concerns the use of a nutritional composition for the treatment of a disorder, which is mediated by a postprandial endocrine or neurological response in a human body, wherein the nutritional composition comprises one or more of a specific protein fraction, a specific carbohydrate fraction and a specific nutritional fiber fraction. | 03-08-2012 |
20120027885 | NUTRITION CONTAINING FAT BLEND - The invention relates to the use of long chain polyunsaturated fatty acids for the manufacture of a nutritional composition for feeding infants of a mother who suffered from a metabolic disorder during pregnancy and to a corresponding composition. Said composition comprises a n-3 polyunsaturated fatty acid fraction containing at least 0.1 wt % docosahexaenoic acid (DHA) based on total weight of the lipid, at least 0.01 wt % n-3 docosapentaenoic acid (DPAn-3) based on total weight of the lipid, and at least 0.01 wt. % eicosapentaenoic acid (EPA) based on total weight of the lipid, wherein the sum of DHA, DPAn-3 and EPA is below 1 wt. % of total lipid. | 02-02-2012 |
20120000925 | LID PART FOR A CONTAINER - A lid part for a container, the lid part is substantially made from a thermoplastic material and includes a connection portion for connection to a rim of a container part and a lid which is pivotably connected to the connection portion. The connection portion includes an access opening and a circumferential first flange surrounding the access opening, the lid including a circumferential lid flange extending towards the connection portion, perimeters of the lid flange and of first flange mutually adapted to allow the lid to close in a sealing manner on the first flange of the connection portion, and an area of the access opening is at least about 50 cm | 01-05-2012 |
20110195918 | METHOD FOR PRODUCING PECTIN HYDROLYSIS PRODUCTS - Methods for the production of pectin hydrolysis products, the pectin hydrolysis products produced in this manner, as well as their use are described. | 08-11-2011 |
20110159163 | METHOD FOR FILTERING MILK - The present invention relates to industrial scale processes for increasing protein concentration in milk, particularly increasing protein concentration and reducing the mineral content in milk. | 06-30-2011 |
20110152184 | Nutritional Composition for Improving Muscle Function and Daily Activity - The invention relates to a nutritional composition comprising | 06-23-2011 |
20110152168 | ANTIADHESIVE CARBOHYDRATES - Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C | 06-23-2011 |
20110150851 | NUTRITIONAL COMPOSITION FOR INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention relates to compositions to be administered to infants delivered via caesarean section and in particular to a product comprising inactivated cells and/or bacterial cell fragments of Gram-negative bacteria and of optionally inactivated Gram-positive bacteria. Thereby it is possible to stimulate a fast colonisation of the intestinal microbiota of said infants. | 06-23-2011 |
20110150824 | Nutritional Composition for Improving the Mammalian Immune System - The invention relates to a nutritional composition comprising
| 06-23-2011 |
20110136732 | INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY - The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months. The composition comprises linoleic acid and alpha-linolenic acid. | 06-09-2011 |
20110091445 | MODULATION OF INTESTINAL FLORA OF HIV PATIENTS - The present invention is in the field of nutrition for HIV-infected subjects and concerns methods and composition comprising dietary fiber for the normalization of the intestinal flora of HIV-infected subjects. | 04-21-2011 |
20110086814 | INHIBITING E.SAKAZAKII GROWTH - The present invention concerns the use of uronic acid saccharide for preventing growth of | 04-14-2011 |
20110034376 | Use of Lipid-Rich Nutrition for the Treatment of Post-Operative Ileus - The invention pertains to the use of a lipid-rich nutrition for the manufacture of a composition for the prevention and/or treatment of post-operative ileus. The lipid fraction inhibited IL-6 and TNF-α levels in peritoneal lavage fluid, and/or wherein the lipid fraction prevents influx of neutrophils in the intestinal muscularis following intestinal manipulation. The nutritional composition comprises at least a lipid fraction which accounts for 42 to 90%, preferably between 45 and 70% of the total energy of the composition. The lipid fraction preferably contains 8 to 50 wt % of phospholipids. | 02-10-2011 |
20110014167 | USE OF PROBIOTICS AND FIBERS FOR DIARRHOEA - The present invention relates to nutritional compositions comprising | 01-20-2011 |
20100316750 | CHOLESTEROL LOWERING SUPPLEMENT - The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as a suitable composition comprising (a) one or more phytosterols and/or phytostanols capable of reducing cholesterol absorption in the intestine and/or one or more soluble fibres capable of inhibiting ileal bile acid absorption, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions (b) and (c) is preferably derived from plants. | 12-16-2010 |
20100260777 | TREATMENT AND/OR PREVENTION OF SEPSIS USING AN ENTERAL COMPOSITION - Treatment and/or prevention of sepsis using an enteral composition containing phospholipids, triglycerides and cholesterol or precursors thereof. With the composition of the invention the natural level of chylomicrons is maintained, in particular in gut associated lymphoid tissue (GALT), which ensures that most of LPS and/or LTA which are released in the body can be neutralized, substantially decreasing the risk of locally occurring high levels of LPS and/or LTA and thus sepsis. | 10-14-2010 |
20100236966 | CONTAINER ASSEMBLY HAVING STACKING MEANS - Container assembly includes a container part and a lid part. The lid part has a connection portion to be connected to the container part. For automatic assembly of the container assembly from the container part and the lid part it is advantageous that separate lid parts can be manipulated easily. To that end it is proposed to embody the lid parts such a way that they are stackable in a stable way. More particular it is proposed to provide the top side of the lid with a circumferential cam which can engage inside a circumferential rim of the connection portion. To be able to remove dust and debris from the top side of the lid it is proposed to provide a circumferential cam with interruptions. When part of the lid is shaped to correspond with part of the spoon, the interruption should preferably located at such shape such as a spoon. | 09-23-2010 |
20100234286 | PRETERM FORMULA - The present invention relates to a method and a composition for feeding low birthweight infants (LBW infants), very low birthweight infants (VLBW infants), extremely low birthweight infants (ELBW infants) and preterm infants for improving oral tolerance. | 09-16-2010 |
20100216740 | Cereal-based Infant Nutrition with Fibre - Cereal-based semi-liquid and/or semi-solid compositions suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid adult foods, comprising uronic acid carbohydrates with a degree of polymerisation (DP) between 10 and 300 and also uses thereof are disclosed. | 08-26-2010 |
20100159109 | DEVICE AND A METHOD FOR PREPARING A READY TO USE LIQUID PRODUCT - The invention relates to a device | 06-24-2010 |
20100136134 | Immune stimulatory infant nutrition - A nutritional or pharmaceutical composition containing a fat component, a protein component and a carbohydrate component and comprising whey and casein. The composition has a weight ratio of casein to whey is 1:1 to 1:2.4 and that the composition contains: a) at least 3 grams arginine per 100 grams protein; b) at least 10 wt. % linoleic acid based on total fatty acids; c) at least 1 wt. % alpha linolenic acid based on total fatty acids; d) at least one long chain-polyunsaturated fatty acid in an amount exceeding 0.1 wt. % based on total fatty acids. The long chain polyunsaturated fatty acid being docosahexaenoic acid, arachidonic acid and eicosapentaenoic acid; e) 5 to 25 wt. % of at least one polyunsaturated fatty acid based on total fatty acids; and f) 2 to 12 grams indigestible oligosaccharides having a degree of polymerisation of 2 to 100 per 100 gram dry weight of the composition. The composition reduces—among others—the risks attached to feeding whey dominant infant formula. | 06-03-2010 |
20100129461 | Process for Dispersing Amino Acids - A coated proteinaceous material can be produced by contacting the proteinaceous material with de-oiled phospholipids or mixtures thereof containing less than 20% triglycerides. The coating has between 0.1 and 1.5% by weight of the total proteinaceous material, of de-oiled lecithin. The proteinaceous material is hydrophobic, especially amino acids having a hydrophobicity of higher than 1.0 kJ/mol. In particular, the amino acids are leucine, isoleucine, valine, phenylalanine, tryptophan and/or methionine. The coated amino acids can be incorporated into food product and medicaments. | 05-27-2010 |
20100120676 | COMPOSITION TO TREAT AND/OR PREVENT GASTROINTESTINAL INFECTION - The invention relates to a composition for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular | 05-13-2010 |
20100086668 | PROCESS FOR PRODUCING SLOWLY DIGESTIBLE STARCH - A sterilised food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 &mgr;m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 &mgr;m; and (c) a non-digestible starch content of less than 50 wt. %; and (d) a slowly digestible starch content of 15-75 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesitas, insulin resistance, or for postprandial glucose response. | 04-08-2010 |
20100075900 | Use of Nutritional Compositions for Preventing Disorders - The present invention relates to a method for preventing and/or treating visceral adiposity by administering a certain nutritional composition to an infant with the age between 0 and 36 months, and preventing the occurrence of diseases later in life. | 03-25-2010 |
20100068213 | SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS - The invention relates to the treatment of intestinal barrier function disorders involving administration of a selected colostrum comprising more than 25 weight % undenatured immunoglobulin G(IgG) based on the weight of total protein content of said colostrum to a subject. The invention further relates to compositions comprising colostrum and indigestible dietary fibers wherein the colostrum comprises more than 25 weight % undenatured immunoglobulin G based on the weight of total protein content of said colostrum. | 03-18-2010 |
20100068149 | Use of nutritional compositions for preventing disorders - The present invention relates to a method for preventing and/or treating visceral adiposity and/or to alter body fat distribution by administering a certain nutritional composition to a human subject with the age between 0 and 48 months, and preventing the occurrence of diseases later in life. | 03-18-2010 |
20090305362 | Process for preparing uronic acid oligosaccharides by extrusion - The present invention provides processes for the manufacture of uronic acid oligosaccharides using extrusion. The uronic acid polymers are extruded with an enzyme, under basic conditions (pH>9) and/or under high shear. | 12-10-2009 |
20090301923 | PACKAGE FOR FLOWABLE GOODS, IN PARTICULAR COMESTIBLES, AND USE OF SUCH PACKAGE DURING TRANSPORTATION, PRESENTATION AND CONSUMPTION - The invention relates to a package for flowable goods, in particular liquid, viscous and/or granular comestibles, such as baby food, pudding, sauce, oatmeal or the like. The package comprises a shallow tray and a cover which in closed condition slants towards a bottom wall of the tray thereby providing the package with a substantially wedge-shaped appearance. The package furthermore comprises two support faces to stand on alternately. A first support face is located at the bottom wall of the tray and a second support face is located at a bottom-surrounding wall of the tray, at the higher end of the wedge. | 12-10-2009 |
20090220639 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 09-03-2009 |
20090215897 | Method for treatment and prevention of respiratory insufficiency - The invention relates to the use of a composition comprising eicosapentaenoic acid 5 (EPA, n-3), docosahexaenoic acid (DHA, n-3) and stearidonic acid (STA) and having a weight ratio STA/DHA of at least 0.1 for the manufacture of a pharmaceutical or nutritional composition for the treatment and/or prevention of dust mite induced respiratory insufficiency and/or dust mite allergy. | 08-27-2009 |
20090203592 | INFANT NUTRITION WITH HYDROLISED PROTEINS - The invention concerns a method to treat and/or prevent childhood obesity comprising administering a nutritional composition containing fat, digestible carbohydrates and protein, wherein the protein comprises at least 25 wt. % peptides with a chain length of 25 to 30 amino acids based on dry weight of protein. | 08-13-2009 |
20090181154 | NON-ALLERGENIC INGREDIENTS AND FOOD PRODUCTS - The present invention relates to a non-allergenic food product, comprising an amino acid fraction comprising at least one component selected from the group consisting of amino acids and peptides having a degree of polymerization of 7 or less; and a lipid fraction comprising at least one fatty acid selected from the group consisting of arachidonic acid and docosahexanoic acid, the composition having a content of proteins and other peptides having a molecular weight of 1000 dalton or more of less than 0.01 wt. %, based on the dry weight, preferably less than 0.001 wt. %, more preferably less than 0.0001 wt %. | 07-16-2009 |
20090162323 | Method for Stimulating the Intestinal Flora - The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | 06-25-2009 |
20090104283 | METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS - The present invention relates to the use of
| 04-23-2009 |
20090082249 | NUTRITIONAL SUPPLEMENT FOR A CATEGORY OF HIV PATIENTS - The present invention relates to a nutritional product for HIV patients that are not on Highly Active Antiretroviral Therapy. More specifically the invention relates to a nutritional composition comprising oligosaccharides. This invention also relates to the manufacture of a nutritional supplement for use in HIV patients. | 03-26-2009 |
20090081179 | METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS - The present invention relates to the use of
| 03-26-2009 |
20090022813 | COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING OF CELLS - It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises
| 01-22-2009 |
20090004342 | Temporally Meal Menu For Infants - The invention concerns a kit of parts and a method for providing nutrition which provides within a time period of 5 to 10 days a nutritional composition comprising 0.35 to 6 mg iron per 100 g, a nutritional composition comprising 1 to 10 g fibre per 100 g and a nutritional composition comprising 10 to 5000 mg long chain poly unsaturated fatty acids per 100 g to an infant. | 01-01-2009 |
20090004164 | Nutritional Composition With Probiotics - A composition comprising | 01-01-2009 |
20080317868 | COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS - It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises:
| 12-25-2008 |
20080292774 | Liquid Transition Nutrition For Infants - Liquid composition suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid foods with a viscosity 20-150 mPas, containing a digestible carbohydrate fraction and an indigestible carbohydrate fraction with at least 50 wt. % soluble indigestible oligosaccharide with a degree of polymerisation (DP) between 2 and 100. | 11-27-2008 |
20080292724 | COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS - It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises:
| 11-27-2008 |
20080292649 | COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING OF CELLS - It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises
| 11-27-2008 |
20080275120 | LEUCINE RICH COMPOSITION - The invention relates to the use of a composition comprising proteinaceous matter, said providing at least 24.0% of the energetic value of the composition (en %) and at least 12 wt. % based on proteinaceous matter leucine in the manufacture of a medicament for the treatment of insulin resistance and to a composition suitable for administration to a mammal comprising a protein fraction, a carbohydrate fraction and a lipid fraction, wherein the protein fraction provides at least 24.0 % (en %), the carbohydrate provides up to 46 en %, the lipid fraction provides up to 30 en % and wherein at least 12 wt. %, based on proteinaceous matter, of leucine. | 11-06-2008 |
20080269330 | Nutrition Containing Fat Blend - The invention relates to the use of long chain polyunsaturated fatty acids for the manufacture of a nutritional composition for feeding infants of a mother who suffered from a metabolic disorder during pregnancy and to a corresponding composition. Said composition comprises a n-3 polyunsaturated fatty acid fraction containing at least 0.1 wt docosahexaenoic acid (DHA) based on total weight of the lipid, at least 0.01 wt % n-3 docosapentaenoic acid (DPAn-3) based on total weight of the lipid, and at least 0.01 wt. % eicosapentaenoic acid (EPA) based on total weight of the lipid, wherein the sum of DHA, DPAn-3 and EPA is below 1 wt. % of total lipid. | 10-30-2008 |
20080207559 | Carbohydrates mixture - A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided according to the present invention. Said carbohydrate mixture is characterized in that they contain or consist of two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed, | 08-28-2008 |